Drug Type Radiolabeled antibody, Diagnostic radiopharmaceuticals |
Synonyms- |
Target |
Mechanism CD45 inhibitors(Leukocyte common antigen inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
B-cell lymphoma recurrent | Phase 2 | US | 09 Oct 2013 | |
B-cell lymphoma refractory | Phase 2 | US | 09 Oct 2013 | |
Mantle cell lymphoma recurrent | Phase 2 | US | 09 Oct 2013 | |
Mantle cell lymphoma refractory | Phase 2 | US | 09 Oct 2013 | |
Recurrent Hodgkin Lymphoma | Phase 2 | US | 09 Oct 2013 | |
Refractory Hodgkin Lymphoma | Phase 2 | US | 09 Oct 2013 | |
T-cell lymphoma recurrent | Phase 2 | US | 09 Oct 2013 | |
T-cell lymphoma refractory | Phase 2 | US | 09 Oct 2013 | |
Multiple Myeloma | Phase 1 | US | 09 Jan 2012 | |
Anemia, Refractory, With Excess of Blasts | Phase 1 | US | 01 Jan 2012 |
Phase 1 | 15 | tumrjqjpgp(tsowfvztfr) = pcoofjtnsg cetdhbiobf (lwobusuqgm ) View more | - | 24 Jul 2020 | |||
Phase 1 | 16 | aiihlhsqsm(aehfdwmdbx) = yntrnqcphr lnwvkpikqj (wrhuzbirdh ) View more | - | 01 Jun 2020 | |||
Fludarabine and 2 Gy total body irradiation | pmpfcpdlpo(bidsjxqoij) = ggoxyduibg smkhnggrxs (yjqiczridu ) |